These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Trypanosoma cruzi-sensitized T-lymphocyte mediated 51CR release from human heart cells in Chagas' disease. Teixeira AR; Teixeira G; Macêdo V; Prata A Am J Trop Med Hyg; 1978 Nov; 27(6):1097-1107. PubMed ID: 83110 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the western blot in the confirmatory serologic diagnosis of Chagas' disease. Reiche EM; Cavazzana M; Okamura H; Tagata EC; Jankevicius SI; Jankevicius JV Am J Trop Med Hyg; 1998 Nov; 59(5):750-6. PubMed ID: 9840592 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of an autoimmune type antibody in the sera of patients with Chagas' disease. Hübsch RM; Sulzer AJ; Kagan IG J Parasitol; 1976 Aug; 62(4):523-7. PubMed ID: 822145 [TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory mechanisms and Chagas' disease. Hontebeyrie-Joskowicz M Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():101-3. PubMed ID: 1342703 [TBL] [Abstract][Full Text] [Related]
10. Chagas' disease: decreased resistance to Trypanosoma cruzi acquired infection in offspring of infected mice. Carlier Y; Rivera MT; Truyens C; Ontivero M; Flament J; Van Marck E; de Maertelaer V Am J Trop Med Hyg; 1992 Feb; 46(2):116-22. PubMed ID: 1539744 [TBL] [Abstract][Full Text] [Related]
12. Placental alkaline phosphatase (PLAP) enzyme activity and binding to IgG in Chagas' disease. Lin S; Sartori MJ; Mezzano L; de Fabro SP Placenta; 2005 Nov; 26(10):789-95. PubMed ID: 16122790 [TBL] [Abstract][Full Text] [Related]
13. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]. Braun M; de Titto E Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884 [TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani donovani antigens recognized by kala-azar patient sera and identification of cross-reacting antigens to Chagas' disease. Andrade CR; Andrade PP; Wright EP Braz J Med Biol Res; 1988; 21(3):511-5. PubMed ID: 3147797 [TBL] [Abstract][Full Text] [Related]
16. Is there a link between the human TRIM21 and Trypanosoma cruzi Clone 36 genes in Chagas' disease? Winkler MA; Pan AA Mol Immunol; 2010; 48(1-3):365-7. PubMed ID: 20709399 [TBL] [Abstract][Full Text] [Related]
17. Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment. Pereira-Chioccola VL; Fragata-Filho AA; Levy AM; Rodrigues MM; Schenkman S Clin Diagn Lab Immunol; 2003 Sep; 10(5):826-30. PubMed ID: 12965912 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease. Gironès N; Rodríguez CI; Basso B; Bellon JM; Resino S; Muñoz-Fernández MA; Gea S; Moretti E; Fresno M Clin Diagn Lab Immunol; 2001 Nov; 8(6):1039-43. PubMed ID: 11687436 [TBL] [Abstract][Full Text] [Related]
19. Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades. Bacal F; Silva CP; Pires PV; Mangini S; Fiorelli AI; Stolf NG; Bocchi EA Clin Transplant; 2010; 24(2):E29-34. PubMed ID: 20088914 [TBL] [Abstract][Full Text] [Related]
20. Chagas' disease: trends in immunological research and prospects for immunoprophylaxis. Teixeira AR Bull World Health Organ; 1979; 57(5):697-710. PubMed ID: 120233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]